• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

bostonscientific

  1. Endoscopy

    What is the realistic plan? I was told 140 but reps have made well over 300-400 by their 3rd year lol how is the team.company culture? The area/division seems smallish. what is the room for actual advancement? do they encourage education or other training? what are the benefits like? And...
  2. Stryker says it will not acquire Boston Scientific

    On Monday, WSJ reported that Stryker is in talks with Boston Scientific for a potential acquisition. But today, Stryker confirmed that it didn't have any discussion with Boston Scientific. https://news.alphastreet.com/stryker-confirms-that-it-didnt-bid-for-boston-scientific/
  3. Boston Scientific 4Q Results

    Boston Scientific (BSX) reported a net loss of $615 million in the fourth quarter due to one-time income tax charge of $842 million. Adjusted earnings came in at $0.34 per share, which improved 13% vs. last year. MedSurg business grew 14% in the fourth quarter raking in $931 million. Check out...